This study demonstrated an improved reduction in plasma glucose levels and a marked increase in blood insulin concentrations at 20- and 135-min after oral insulin administration, when co-administered with a peptidase or proteinase inhibitor, in both lean and obesity-induced diabetes rat models. Here, INS is linked to obesity disorder.